• About Us
  • Investment Criteria
  • Portfolio
  • Our Team
  • News
  • Contact Us
☰
  • About Us
  • Investment Criteria
  • Portfolio
  • Our Team
  • News
  • Contact Us
Posted on April 1, 2006December 1, 2017 by admin

April, 2006

Greyrock Capital provides $5.0 million to support Alaven Pharmaceutical’s acquisition of niche pharmaceutical products.
CategoriesNews, Uncategorized

Post navigation

Previous PostPrevious March, 2006
Next PostNext May 2006

Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

Search

About This Site

This may be a good place to introduce yourself and your site or include some credits.

© 2017 Greyrock Capital Group. All Rights Reserved.

Developed by Synergy Networx